恆生科技指數曾急彈4.6% 騰訊/金山/京東/美團反彈5%-7%
市場權衡美國疫苗研發露曙光和新增確診病例激增及經濟反彈的可能時機，資金重新由舊經濟股轉投科技股，美國大型科技股扭轉連日頹勢，尤其是蘋果及亞馬遜反彈3%及3.4%，費城半導體指數更急彈3.7%，帶動納指昨晚急彈2%，結束兩連跌。不過，納指一百期貨今早回吐0.4%報11,838。
內地加強監管金融科技、網絡小貸和互聯網平台。中資科技股連續兩天捱沽後，今早扭轉昨天低收急跌頹勢，本港恆生科技指數一舉重越50天及20天線(7,721)，曾回升4.6%高見7,812，現造7,721，反彈3.4%。
四大重磅科技股繼昨天低收續挫近8%-10%後，今早全面顯著反彈，今天放榜的重騰訊(00700.HK)曾重越20天線(584.3元)，最高見585元，現造578.5元，急彈5%；阿里巴巴-SW(09988.HK)最高見258.6元，受制百天線(261.6元)，現造255.2元，回升2.7%。美團-W(03690.HK)及小米-W(01810.HK)分別重越20天線(287.1元)及20天與10天線(22.8元及23.6元)，最高見298元24元，現造290元及23.6元，反彈7%及4.2%。
京東-SW(09618.HK)重越50天線(310.5元)，最高見323.2元，現造319.6元，反彈6.5%。中芯(00981.HK)高見23.45元(剛為10天線)，現造23.1元，回升2.7%。上季少賺61%的華虹半導體(01347.HK)扭轉昨天急挫14%頹勢，曾一舉收復20天及10天線(29.7元及31元)，最高見31.35元，現造30.75元，回升3.7%。
金蝶(00268.HK)及金山軟件(03888.HK)由紀錄高位連吐兩天及三天後，今早高見24元及41.65元，現造23.35元及41.4元，回升4.7%及5.3%，前者股價重越10天線(22.7元)，後者股價重越100天、50天及20天線(39.95-40.95元)。丘鈦科技(01478.HK)重越10天線，股價回升4%曾高見9.77元。
微盟(02013.HK)重越20天及10天線(10.5-10.6元)，最高見10.94元，現造10.74元，回升4.5%。此外，阿里健康(00241.HK)及平安好醫生(01833.HK)彈4.5%及3.8%，分別高見19.98元及100.5元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
